So they have no customers but are still projecting sales of $25 to $35M....
So now lets look at a few other coys on the asx that have a market cap of $115M or SP at approx .30c and have sales at $25 to $35M.......
Lets look at previous market darling EDE...oops not a lot of sales there....
AJX.....SP around .50c
RAP....Nope, no sales there
The product QIN produces is 'real', it is not a virtual product, it already really exists. It has a value, irrespective of what we think that value should be, there are customers for that product out there, so why are we treating this coy as if it was a tech/pharma stock?
A debt to equity swap would place QIN back into stability very quickly IMO as without any pressing need to repay debt, the coy will quickly sort its sh*t out.
I agree the board and management has done some dumb stuff, they deserve a spill, certainly a strike, but the inherent value of the products exists. Whether the coy can survive to receive that value (and therefore the shareholders) appears to be a game that is being played by others that the SH have little say in.
- Forums
- ASX - By Stock
- QIN
- Ann: Response to ASX query letter
Ann: Response to ASX query letter, page-17
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online